Literature DB >> 24391395

Glucarpidase (voraxaze), a carboxypeptidase enzyme for methotrexate toxicity.

Mohammad A Rattu, Neal Shah, Jessica M Lee, Antony Q Pham, Nino Marzella.   

Abstract

Glucarpidase (Voraxaze) for methotrexate toxicity.

Entities:  

Year:  2013        PMID： 24391395      PMCID： PMC3875266     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  27 in total

1.  Hazards of concomitant administration of methotrexate and glutamine.

Authors:  Juan F Marín Pozo; Javier Aranda García; Aurelio Cabello Muriel; Isabel Caba Porras
Journal:  Am J Health Syst Pharm       Date:  2010-04-15       Impact factor: 2.637

2.  Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.

Authors:  Brigitte C Widemann; Frank M Balis; AeRang Kim; Matthew Boron; Nalini Jayaprakash; Aiman Shalabi; Michelle O'Brien; Michelle Eby; Diane E Cole; Robert F Murphy; Elizabeth Fox; Percy Ivy; Peter C Adamson
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.

Authors:  B C Widemann; F M Balis; R F Murphy; J M Sorensen; M J Montello; M O'Brien; P C Adamson
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

4.  Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.

Authors:  Ali McBride; Scott J Antonia; Eric B Haura; Dawn Goetz
Journal:  J Pharm Pract       Date:  2012-05-01

5.  Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.

Authors:  Brigitte C Widemann; Frank M Balis; Aiman Shalabi; Matthew Boron; Michelle O'Brien; Diane E Cole; Nalini Jayaprakash; Percy Ivy; Valerie Castle; Karin Muraszko; Christopher L Moertel; Robert Trueworthy; Robert C Hermann; Ali Moussa; Stuart Hinton; Gregory Reaman; David Poplack; Peter C Adamson
Journal:  J Natl Cancer Inst       Date:  2004-10-20       Impact factor: 13.506

6.  Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.

Authors:  A S O'Marcaigh; C M Johnson; W A Smithson; M C Patterson; B C Widemann; P C Adamson; M J McManus
Journal:  Mayo Clin Proc       Date:  1996-02       Impact factor: 7.616

Review 7.  Central and peripheral nervous system toxicity of common chemotherapeutic agents.

Authors:  Chrissa Sioka; Athanassios P Kyritsis
Journal:  Cancer Chemother Pharmacol       Date:  2008-11-25       Impact factor: 3.333

8.  Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.

Authors:  Marc Phillips; William Smith; Guhan Balan; Suzanne Ward
Journal:  J Clin Pharmacol       Date:  2008-01-11       Impact factor: 3.126

9.  Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase.

Authors:  A Mary Vilay; Bruce A Mueller; Hilary Haines; Jeffery A Alten; David J Askenazi
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

10.  Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.

Authors:  S Buchen; D Ngampolo; R G Melton; C Hasan; A Zoubek; G Henze; U Bode; G Fleischhack
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640
View more
  4 in total

1.  Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N10-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate.

Authors:  Michael S Roberts; Nicholas S Selvo; Jessica K Roberts; Vinay M Daryani; Thandranese S Owens; K Elaine Harstead; Amar Gajjar; Clinton F Stewart
Journal:  J Liq Chromatogr Relat Technol       Date:  2016-10-10       Impact factor: 1.312

2.  Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.

Authors:  Lauren R Schaff; Mina Lobbous; Dean Carlow; Ryan Schofield; Igor T Gavrilovic; Alexandra M Miller; Jacqueline B Stone; Anna F Piotrowski; Ugur Sener; Anna Skakodub; Edward P Acosta; Kevin J Ryan; Ingo K Mellinghoff; Lisa M DeAngelis; Louis B Nabors; Christian Grommes
Journal:  BMC Cancer       Date:  2022-01-13       Impact factor: 4.430

Review 3.  Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response.

Authors:  Huanhuan Yan; Rui Su; Hongwei Xue; Chong Gao; Xiaofeng Li; Caihong Wang
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

4.  A Two-Way Interaction between Methotrexate and the Gut Microbiota of Male Sprague-Dawley Rats.

Authors:  Marine P M Letertre; Nyasha Munjoma; Kate Wolfer; Alexandros Pechlivanis; Julie A K McDonald; Rhiannon N Hardwick; Nathan J Cherrington; Muireann Coen; Jeremy K Nicholson; Lesley Hoyles; Jonathan R Swann; Ian D Wilson
Journal:  J Proteome Res       Date:  2020-07-06       Impact factor: 4.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.